At a glance
ClinicalIndex Comparison RecordN/ACompleted· 8 enrolled
Drug / intervention
The ZELTIQ Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Feasibility Study to Explore the Safety and Efficacy of Cryolipolysis Followed by Radiofrequency Treatment for Submental and Submandibular Contouring
In Brief
A clinical study evaluating The ZELTIQ System for Body Fat Disorder. Completed, enrolled 8 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of sequential use of CoolSculpting (Cryolipolysis) and radiofrequency treatment of the submental and submandibular area.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBody Fat Disorder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartDec 2018
First PostedMar 2019
Primary CompletionJun 2019
TodayJul 2026
First PostedMar 13, 2019
Enrollment StartDec 18, 2018
Primary CompletionJun 18, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.3 years ago
Interventions
The ZELTIQ Systemdevice
Participants received cryolipolysis treatment in submental and submandibular areas using the CoolSculpting System and CoolMini applicator for fat layer reduction on Day 0, which was followed with a radiofrequency treatment performed 12 weeks after CoolSculpting.